A Phase 1/2 Multidose, Dose Escalation Study To Evaluate Rxi-109 Administered By Intravitreal Injection To Reduce The Progression Of Subretinal Fibrosis In Subjects With Advanced Neovascular Amd (Nvamd)
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE(2017)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要